September 28, 2013
Edmondson's football team will have its usual Monday conditioning session on Sunday this week, for a good cause. The Red Storm will race in the ZERO Prostate Cancer Run Sunday morning at 8:30 at Towson University. Coach Corey Johnson told the players they could have Monday off from conditioning if they participate in the fund-raising 5K scheduled for the last weekend of Prostate Cancer Awareness Month. Johnson said the idea originated with Edmondson principal Karl Perry Sr. after Dr. Sanford Siegel, the president and CEO of Chesapeake Urology, mentioned the race to him. “My principal thought it would be a great way to get the guys involved and also help to bring awareness,” Johnson said, adding that Siegel picked up the $30 entry fee for each of the Red Storm players and Perry provided a bus. “They wanted to bring awareness of prostate cancer particularly to the African American community,” Johnson said, “because it really affects African American men at a much higher rate than others.
September 6, 2014
A white powdered chemical compound emerged from two University of Maryland School of Medicine laboratories more than 10 years ago with a name destined for oblivion, but a future that now looks promising as a treatment for the most challenging cases of prostate cancer. Today, VN/124-1 is a drug candidate with a name - galeterone - a pharmaceutical company founded on its potential and a record of strong preliminary results in clinical trials with human patients. The Food and Drug Administration has put galeterone on a fast track for approval to treat prostate cancer, which kills about 30,000 men a year in the United States.
May 30, 2012
For years, the PSA test has been the standard method for early detection of prostate cancer, which strikes one in six men. But recently, the U.S. Preventive Services Task Force, a federal advisory panel, said the test that checks for prostate-specific antigens should not be routinely given to healthy men because it doesn't save enough lives to warrant all the extra treatment and stress stemming from the tests. Some men die of complications from surgery to remove the prostate, and many others suffer side effects.
January 11, 2012
Researchers at Johns Hopkins and the University of Michigan have discovered an inherited mutation linked to significantly higher risk of prostate cancer development at a younger age. The discovery, after two decades of looking, provides insight into the disease development. And though those with the mutation comprise just a fraction of the 240,000 new cases diagnosed annually, the discovery could also help doctors determine who needs earlier screening. The discovery is the first major genetic variant found for inherited prostate cancer, said Dr. Kathleen A. Cooney, professor of internal medicine and urology at the Michigan Medical School and a senior author of the study, which was published in the New England Journal of Medicine . The study found that those with a family history of prostate cancer were much more likely to have the mutation, and that gave them a 10-20 higher risk of developing the disease themselves.
June 8, 2005
Doctors are offering free screenings for prostate cancer from 9 a.m. to 5 p.m. tomorrow and Friday in a mobile lab outside the Safeway at 2401 N. Charles St. The "Do it for Dad" drive against prostate cancer is sponsored by the Johns Hopkins Kimmel Cancer Center, the National Prostate Cancer Coalition and the Family Health Center of Baltimore. Doctors will conduct the two-part testing inside a 39-foot-long Airstream Land Yacht XL. It will include a blood test and a physical exam. Maryland ranks 10th in the nation in incidence of prostate cancer and in mortality.
April 28, 1992
A number of men in public life are talking publicly these days about their prostate cancer -- a disease that until recently few men wanted to discuss, and many agree the time for public airing is overdue.Details on Page 1C